查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體外膜氧療市場——按方式、按應用、按患者人數分類，全球預測，2023-2032 年
市場調查報告書
商品編碼
1267471

體外膜氧療市場——按方式、按應用、按患者人數分類，全球預測，2023-2032 年

Extracorporeal Membrane Oxygenation Market - By Modality, By Application, By Patient Population & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

由於歐洲政府舉措和計劃的增加，到 2032 年，全球體外膜氧療 (ECMO) 市場預計將顯著增長。

近年來，歐洲的呼吸道和心血管疾病患病率顯著上升，預計這一趨勢在預測期內將持續下去。 CVD 病例的增加導致政府採取措施和各種計劃來提高公眾意識。 政府對新興國家基礎設施發展的資助將有助於使昂貴的機器更容易獲得，並促進該行業的收入增長。

例如，2021 年 1 月，Braile Biomedica 與 Eldorado Institute 和 Embrapii 合作推出了 SOLIS 系統，這是一款針對 COVID-19 的全國性產品。 ECMO（體外膜氧合），一種體外呼吸，構成了這個系統。 這樣的產品介紹使公司能夠確保其在市場上的地位。

ECMO 市場根據方法、類型、患者人數和地理位置進行細分。

根據我們的方法，靜脈 (VV) 部分在 2022 年持有超過 1.8 億美元。 靜脈 ECMO 設備是一種增加血流量和氧氣濃度，同時減輕心臟負擔和支持血液動力學的設備。 預計在預測期內，心肺疾病負擔的增加將增加對靜脈 ECMO 的需求。

從 2023 年到 2032 年，按類型劃分，呼吸領域預計將以超過 3% 的複合年增長率增長。 該細分市場增長的一個關鍵因素是患有各種呼吸系統疾病的人出現呼吸衰竭的風險。 此外，易患呼吸系統疾病的老年人口不斷增加，將進一步完善不斷增長的市場環境。

根據患者人口統計，成人細分市場預計在整個預測期內將出現積極的市場擴張。 不斷增長的老年人口和越來越多的傳染病和慢性病患者將推動對 ECMO 治療的需求。 用於治療成人患者的 ECMO 技術的進步也有望促進該行業的發展。

按地區劃分，從 2023 年到 2032 年，拉丁美洲體外膜氧療 (ECMO) 市場預計將以超過 4% 的複合年增長率增長。 這是由於尖端 ECMO 技術在拉丁美洲國家醫療機構中的使用迅速增加，以及該地區呼吸系統疾病和心髒病的發病率上升。 此外，該地區的擴張也將受益於受 COVID-19 影響的國家對 ECMO 設備需求的增加。

內容

第一章研究方法論

  • 調查方法
  • 市場範圍和定義
  • 基本估算和計算結果
  • 預測計算
  • 數據驗證
  • 數據源
    • 主要數據
    • 二手數據
      • 付費資源
      • 無償來源

第 2 章執行摘要

第 3 章：體外膜氧療行業洞察

  • 2018-2032 年行業格局
  • 影響行業的因素
    • 司機
      • 亞太地區心肺疾病和呼吸衰竭病例增加
      • ECMO設備的技術進展
      • 拉丁美洲患者對體外膜氧療益處的認識不斷提高
      • 歐洲政府舉措和計劃的增加
    • 行業潛在的風險和挑戰
      • 設備成本高
      • 缺乏熟練的專業人員
      • 與 ECMO 設備相關的風險
  • 增長分析
    • 按方式
    • 通過使用
    • 患者分層
  • COVID-19 影響分析
  • 監管狀況
    • 美國
    • 歐洲
  • ECMO 治療量，按地區
  • 波特分析
  • PESTEL 分析

第四章競爭格局

  • 介紹
  • 競爭儀表板，2021 年
  • 每家公司的市場份額（2021 年）
  • 主要市場參與者的競爭分析
  • 競爭對手定位矩陣
  • 戰略視角矩陣

第 5 章體外膜氧療市場：按方式分類

  • 主要細分趨勢
  • 靜脈動脈 (VA)
  • 靜脈型 (VV)
  • 動靜脈 (AV)

第 6 章體外膜氧療市場：按應用

  • 主要細分趨勢
  • 心髒病
  • 呼吸系統疾病
  • 體外心肺復蘇 (ECPR)

第 7 章體外膜氧療市場：患者細分

  • 主要細分趨勢
  • 嬰兒
  • 兒科
  • 成人

第 8 章體外膜氧療市場：按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 台灣
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 卡塔爾
    • 阿聯酋

第九章公司簡介

  • Abbott Laboratories
  • Fresenius Medical Care AG & Co. KGaA
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Abiomed, Eurosets
  • Getinge AB
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro
  • SB-Kawasumi Laboratories, Inc.
  • Spectrum Medical, Terumo Corporation
Product Code: 2720

The global extracorporeal membrane oxygenation (ECMO) market is speculated to grow significantly through 2032 owing to increasing government initiatives as well as programs in Europe.

The prevalence of respiratory and cardiovascular illnesses has increased dramatically throughout the European region in recent years, and this trend is expected to continue over the forecast time. An increase in CVD cases has led to introduction of government measures and implementation of different programs in the area to raise public awareness. Government funding for infrastructure development in emerging nations would help make expensive machines more accessible, which will boost industry revenue growth.

For instance, in January 2021, Braile Biomedica, in collaboration with the Eldorado Institute and Embrapii, introduced the SOLIS System, a nationwide product against COVID-19. Extracorporeal membrane oxygenation (ECMO), a type of extracorporeal breathing, makes up the system. The corporation has benefited from such product introductions in securing its market position.

The ECMO market has been divided in terms of approach, type, patient population, and region.

Based on approach, the veno-venous (VV) segment held more than $180 million in 2022. The veno-venous ECMO device increases blood flow and oxygen levels while reducing cardiac effort and supporting hemodynamics. There will likely be a rise in demand for veno-venous ECMO through the forecast years due to the growing burden of cardiopulmonary diseases.

With respect to type, the respiratory segment is poised to grow at more than 3% CAGR from 2023 to 2032. A significant factor in the segment's growth is the risk of respiratory failure among individuals with different respiratory illnesses. Besides, the expanding geriatric population that is vulnerable to respiratory ailments, would further complement the growing market landscape.

In terms of the patient population, the adult segment is projected to foresee positive market expansion through the forecast years. The need for ECMO treatments will be driven by the growing elderly population base and the rise in the number of people with infectious and chronic diseases. Moreover, advancements in ECMO technology for treating adults is likely to contribute to the industry expansion.

From the regional front, the Latin America extracorporeal membrane oxygenation (ECMO) market is estimated to grow at more than 4% CAGR from 2023 to 2032. The expansion is fueled by the burgeoning use of cutting-edge ECMO technology in healthcare settings in LATAM nations along with the region's rising respiratory and cardiac disease rates. Additionally, the regional expansion will also benefit from the increased ECMO device demand in the COVID-19-affected nations.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates and calculations
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Extracorporeal membrane oxygenation industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Modality trends
    • 2.1.3 Application trends
    • 2.1.4 Patient population trends
    • 2.1.5 Regional trends

Chapter 3 Extracorporeal Membrane Oxygenation Industry Insights

  • 3.1 Industry landscape, 2018-2032
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in cases of cardiopulmonary disease and respiratory failure in Asia Pacific
      • 3.2.1.2 Technological advancements in ECMO devices
      • 3.2.1.3 Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation devices in Latin America
      • 3.2.1.4 Rising government initiatives and programs in Europe
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of equipment
      • 3.2.2.2 Dearth of skilled professionals
      • 3.2.2.3 Risks related to ECMO device
  • 3.3 Growth potential analysis
    • 3.3.1 By modality
    • 3.3.2 By application
    • 3.3.3 By patient population
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 ECMO procedure volume, by region
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape

  • 4.1 Introduction
  • 4.2 Competitive dashboard, 2021
  • 4.3 Company market share, 2021
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic outlook matrix

Chapter 5 Extracorporeal Membrane Oxygenation Market, By Modality

  • 5.1 Key segment trends
  • 5.2 Venoarterial (VA)
    • 5.2.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 5.3 Veno-venous (VV)
    • 5.3.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 5.4 Arteriovenous (AV)
    • 5.4.1 Market estimates and forecast, 2018-2032 (USD Million)

Chapter 6 Extracorporeal Membrane Oxygenation Market, By Application

  • 6.1 Key segment trends
  • 6.2 Cardiac diseases
    • 6.2.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 6.3 Respiratory diseases
    • 6.3.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 6.4 Extracorporeal cardiopulmonary resuscitation (ECPR)
    • 6.4.1 Market estimates and forecast, 2018-2032 (USD Million)

Chapter 7 Extracorporeal Membrane Oxygenation Market, By Patient Population

  • 7.1 Key segment trends
  • 7.2 Infant
    • 7.2.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 7.3 Pediatric
    • 7.3.1 Market estimates and forecast, 2018-2032 (USD Million)
  • 7.4 Adult
    • 7.4.1 Market estimates and forecast, 2018-2032 (USD Million)

Chapter 8 Extracorporeal Membrane Oxygenation Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Taiwan
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Qatar
    • 8.6.4 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Fresenius Medical Care AG & Co. KGaA
  • 9.3 Braile Biomedica
  • 9.4 Edwards Lifesciences Corporation
  • 9.5 Abiomed, Eurosets
  • 9.6 Getinge AB
  • 9.7 LivaNova PLC
  • 9.8 Medtronic
  • 9.9 MicroPort Scientific Corporation
  • 9.10 Nipro
  • 9.11 SB-Kawasumi Laboratories, Inc.
  • 9.12 Spectrum Medical, Terumo Corporation

Data Tables

  • TABLE 1 ECMO market, 2018 - 2024 (USD Million)
  • TABLE 2 ECMO market, 2025 - 2032 (USD Million)
  • TABLE 3 ECMO market, by modality, 2018 - 2024 (USD Million)
  • TABLE 4 ECMO market, by modality, 2025 - 2032 (USD Million)
  • TABLE 5 ECMO market, by application, 2018 - 2024 (USD Million)
  • TABLE 6 ECMO market, by application, 2025 - 2032 (USD Million)
  • TABLE 7 ECMO market, by patient population, 2018 - 2024 (USD Million)
  • TABLE 8 ECMO market, by patient population, 2025 - 2032 (USD Million)
  • TABLE 9 ECMO market, by region, 2018 - 2024 (USD Million)
  • TABLE 10 ECMO market, by region, 2025 - 2032 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Number of ECMO procedures, by region, 2018-2024
  • TABLE 13 Number of ECMO procedures, by region, 2025-2032
  • TABLE 14 Venoarterial (VA) market size, by region, 2018 - 2024 (USD Million)
  • TABLE 15 Venoarterial (VA) market size, by region, 2025 - 2032 (USD Million)
  • TABLE 16 Veno-venous (VV) market size, by region, 2018 - 2024 (USD Million)
  • TABLE 17 Veno-venous (VV) market size, by region, 2025 - 2032 (USD Million)
  • TABLE 18 Arteriovenous (AV) market size, by region, 2018 - 2024 (USD Million)
  • TABLE 19 Arteriovenous (AV) market size, by region, 2025 - 2032 (USD Million)
  • TABLE 20 Cardiac disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 21 Cardiac disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 22 Respiratory disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 23 Respiratory disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 24 ECPR market size, by region, 2018 - 2024 (USD Million)
  • TABLE 25 ECPR market size, by region, 2025 - 2032 (USD Million)
  • TABLE 26 Infant market size, by region, 2018 - 2024 (USD Million)
  • TABLE 27 Infant market size, by region, 2025 - 2032 (USD Million)
  • TABLE 28 Pediatric disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 29 Pediatric disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 30 Adult disease market size, by region, 2018 - 2024 (USD Million)
  • TABLE 31 Adult disease market size, by region, 2025 - 2032 (USD Million)
  • TABLE 32 North America ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 33 North America ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 34 North America ECMO market size, by Product, 2018 - 2024 (USD Million)
  • TABLE 35 North America ECMO market size, by product, 2025 - 2032 (USD Million)
  • TABLE 36 North America ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 37 North America ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 38 North America ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 39 North America ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 40 North America ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 41 North America ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 42 U.S. ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 43 U.S. ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 44 U.S. ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 45 U.S. ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 46 U.S. ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 47 U.S. ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 48 Canada ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 49 Canada ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 50 Canada ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 51 Canada ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 52 Canada ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 53 Canada ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 54 Europe ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 55 Europe ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 56 Europe ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 57 Europe ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 58 Europe ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 59 Europe ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 60 Europe ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 61 Europe ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 62 Germany ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 63 Germany ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 64 Germany ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 65 Germany ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 66 Germany ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 67 Germany ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 68 UK ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 69 UK ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 70 UK ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 71 UK ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 72 UK ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 73 UK ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 74 France ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 75 France ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 76 France ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 77 France ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 78 France ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 79 France ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 80 Italy ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 81 Italy ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 82 Italy ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 83 Italy ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 84 Italy ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 85 Italy ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 86 Spain ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 87 Spain ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 88 Spain ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 89 Spain ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 90 Spain ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 91 Spain ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 92 Asia Pacific ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 93 Asia Pacific ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 94 Asia Pacific ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 95 Asia Pacific ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 96 Asia Pacific ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 97 Asia Pacific ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 98 Asia Pacific ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 99 Asia Pacific ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 100 India ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 101 India ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 102 India ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 103 India ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 104 India ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 105 India ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 106 China ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 107 China ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 108 China ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 109 China ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 110 China ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 111 China ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 112 Japan ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 113 Japan ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 114 Japan ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 115 Japan ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 116 Japan ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 117 Japan ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 118 Taiwan ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 119 Taiwan ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 120 Taiwan ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 121 Taiwan ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 122 Taiwan ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 123 Taiwan ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 124 Latin America ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 125 Latin America ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 126 Latin America ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 127 Latin America ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 128 Latin America ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 129 Latin America ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 130 Latin America ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 131 Latin America ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 132 Brazil ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 133 Brazil ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 134 Brazil ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 135 Brazil ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 136 Brazil ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 137 Brazil ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 138 Mexico ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 139 Mexico ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 140 Mexico ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 141 Mexico ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 142 Mexico ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 143 Mexico ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 144 Argentina ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 145 Argentina ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 146 Argentina ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 147 Argentina ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 148 Argentina ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 149 Argentina ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 150 Middle East & Africa ECMO market size, by country, 2018 - 2024 (USD Million)
  • TABLE 151 Middle East & Africa ECMO market size, by country, 2025 - 2032 (USD Million)
  • TABLE 152 Middle East & Africa ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 153 Middle East & Africa ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 154 Middle East & Africa ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 155 Middle East & Africa ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 156 Middle East & Africa ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 157 Middle East & Africa ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 158 South Africa ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 159 South Africa ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 160 South Africa ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 161 South Africa ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 162 South Africa ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 163 South Africa ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 164 Saudi Arabia ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 165 Saudi Arabia ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 166 Saudi Arabia ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 167 Saudi Arabia ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 168 Saudi Arabia ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 169 Saudi Arabia ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 170 Qatar ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 171 Qatar ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 172 Qatar ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 173 Qatar ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 174 Qatar ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 175 Qatar ECMO market size, by patient population, 2025 - 2032 (USD Million)
  • TABLE 176 UAE ECMO market size, by modality, 2018 - 2024 (USD Million)
  • TABLE 177 UAE ECMO market size, by modality, 2025 - 2032 (USD Million)
  • TABLE 178 UAE ECMO market size, by application, 2018 - 2024 (USD Million)
  • TABLE 179 UAE ECMO market size, by application, 2025 - 2032 (USD Million)
  • TABLE 180 UAE ECMO market size, by patient population, 2018 - 2024 (USD Million)
  • TABLE 181 UAE ECMO market size, by patient population, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG 1 Industry segmentation
  • FIG 2 Global extracorporeal membrane oxygenation market, 2018 - 2032 (USD Million)
  • FIG 3 Industry ecosystem
  • FIG 4 Growth potential analysis, by modality
  • FIG 5 Growth potential analysis, by application
  • FIG 6 Growth potential analysis, by patient population
  • FIG 7 Porter's analysis
  • FIG 8 PESTEL analysis
  • FIG 9 Key segment trends, by modality
  • FIG 10 Key segment trends, by application
  • FIG 11 Key segment trends, by patient population
  • FIG 12 Strategy dashboard